Virtus LifeSci Biotech Products ETF
15 hedge funds and large institutions have $9.68M invested in Virtus LifeSci Biotech Products ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$289K | |
| 2 | +$95.2K | |
| 3 | +$59.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$39.8K |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$231K | |
| 3 | -$185K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$172K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$81.1K |